General Nurse Practitioner News

NP

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wild JM et al. – Since the probability of VAVFL is positively associated with treatment duration, careful assessment of the risk–benefit ratio of continuing treatment with vigabatrin is recommended in patients currently receiving this drug. All patients continuing to receive vigabatrin should undergo visual field examination at least every 6 months for the duration of treatment.

Today in Mental Health...keeping you current

Understanding Anxiety Sensitivity in the Development of Anxious and Depressive Symptoms
Cognitive Therapy and Research, 11/25/09

Metabolic Alterations in the Amygdala in Borderline Personality Disorder: A Proton Magnetic Resonance Spectroscopy Study
Biological Psychiatry, 11/25/09

Racial and Ethnic Differences in the Mental Health Needs and Access to Care of Older Adults in California
Journal of the American Geriatrics Society, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address